Cargando…
Biodegradable polymer versus second‐generation durable polymer drug‐eluting stents in patients with coronary artery disease: A meta‐analysis
AIMS: Biodegradable polymer drug‐eluting stents (BP‐DES) were developed in hopes of reducing the risk of stent thrombosis. The comparison of this new stent platform with second‐generation durable polymer drug‐eluting stents (DP‐DES) has not been well described. We, therefore, performed a meta‐analys...
Autores principales: | Wu, James J., Way, Joshua A.H., Roy, Probal, Yong, Andy, Lowe, Harry, Kritharides, Leonard, Brieger, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242365/ https://www.ncbi.nlm.nih.gov/pubmed/30623046 http://dx.doi.org/10.1002/hsr2.93 |
Ejemplares similares
-
Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis
por: Wu, James J., et al.
Publicado: (2018) -
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020) -
Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2013) -
Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017) -
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
por: Navarese, Eliano P, et al.
Publicado: (2013)